Anemocyte

Anemocyte does not have its own clinical-stage therapeutics but provides GMP-compliant contract development and manufacturing services to the cell and gene therapy sector. It specializes in plasmid DNA and mRNA production as well as advanced cell processing—including non‑viral genetic modification—enabling clients' preclinical through commercial programs. The company has expanded capacity significantly since its founding and operates state-of-the-art facilities in Italy with recent expansion into the US market. It has established itself as a key partner in Europe’s advanced therapy ecosystem by offering rapid turnaround times, high-quality standards, and innovative logistics solutions such as drone-based drug transport.